Cannabidiol and neuroprotection: evidence from preclinical studies (2017)
Schröder, N.; Silva, V. K.; Hallak, Jaime Eduardo Cecilio 
; Zuardi, Antonio Waldo; Crippa, José Alexandre de Souza
Source: Handbook of Cannabis and related pathologies: biology, pharmacology, diagnosis, and treatment. Unidade: FMRP
Subjects: CANNABIS, ANTIOXIDANTES, DOENÇA DE ALZHEIMER, ANÓXIA, ISQUEMIA, FERRO, MODELOS ANIMAIS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SCHRÖDER, N. et al. Cannabidiol and neuroprotection: evidence from preclinical studies. Handbook of Cannabis and related pathologies: biology, pharmacology, diagnosis, and treatment. Tradução . London: Elsevier, 2017. p. 1143 . Disponível em: https://doi.org/10.1016/B978-0-12-800756-3.00095-8. Acesso em: 01 maio 2024.APA
Schröder, N., Silva, V. K., Hallak, J. E. C., Zuardi, A. W., & Crippa, J. A. de S. (2017). Cannabidiol and neuroprotection: evidence from preclinical studies. In Handbook of Cannabis and related pathologies: biology, pharmacology, diagnosis, and treatment (p. 1143 ). London: Elsevier. doi:10.1016/B978-0-12-800756-3.00095-8NLM
Schröder N, Silva VK, Hallak JEC, Zuardi AW, Crippa JA de S. Cannabidiol and neuroprotection: evidence from preclinical studies [Internet]. In: Handbook of Cannabis and related pathologies: biology, pharmacology, diagnosis, and treatment. London: Elsevier; 2017. p. 1143 .[citado 2024 maio 01 ] Available from: https://doi.org/10.1016/B978-0-12-800756-3.00095-8Vancouver
Schröder N, Silva VK, Hallak JEC, Zuardi AW, Crippa JA de S. Cannabidiol and neuroprotection: evidence from preclinical studies [Internet]. In: Handbook of Cannabis and related pathologies: biology, pharmacology, diagnosis, and treatment. London: Elsevier; 2017. p. 1143 .[citado 2024 maio 01 ] Available from: https://doi.org/10.1016/B978-0-12-800756-3.00095-8
